Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Šárka Doleželová"'
Autor:
Lenka Sedláková, Věra Čertíková Chábová, Šárka Doleželová, Petra Škaroupková, Libor Kopkan, Zuzana Husková, Lenka Červenková, Soňa Kikerlová, Ivana Vaněčková, Janusz Sadowski, Elzbieta Kompanowska-Jezierska, Petr Kujal, Herbert J. Kramer, Luděk Červenka
Publikováno v:
Clinical and Experimental Hypertension, Vol 39, Iss 2, Pp 183-195 (2017)
Background: Early addition of endothelin (ET) type A (ETA) receptor blockade to complex renin–angiotensin system (RAS) blockade has previously been shown to provide better renoprotection against progression of chronic kidney disease (CKD) in Ren-2
Externí odkaz:
https://doaj.org/article/069801b85c634eb1ad2d34b86397326b
Autor:
Herbert J. Kramer, Petr Kujal, Lenka Červenková, Luděk Červenka, Soňa Kikerlová, Lenka Sedláková, Janusz Sadowski, Zuzana Husková, Věra Čertíková Chábová, Elzbieta Kompanowska-Jezierska, Šárka Doleželová, Petra Škaroupková, Libor Kopkan, Ivana Vaněčková
Publikováno v:
Clinical and Experimental Hypertension. 39:183-195
Background: Early addition of endothelin (ET) type A (ETA) receptor blockade to complex renin–angiotensin system (RAS) blockade has previously been shown to provide better renoprotection against pr...
Autor:
Janusz Sadowski, Elzbieta Kompanowska-Jezierska, Luděk Červenka, Šárka Doleželová, Šárka Jíchová, Libor Kopkan
Publikováno v:
The American Journal of the Medical Sciences. 352:618-630
Background Malignant hypertension is a life-threatening condition, and its pathophysiology is still poorly understood. The present study was designed to evaluate the role of interaction of the renin-angiotensin system with 20-hydroxyeicosatetraenoic
Autor:
Jan Malý, Jan Pirk, Martin Pokorný, Zdeňka Vaňourková, Janusz Sadowski, H. Maxová, Šárka Doleželová, Jan Sochman, Ludek Cervenka, Iveta Mrázová, Ivan Netuka, Lenka Červenková, Vojtěch Melenovský
Publikováno v:
Scopus-Elsevier
The present experiments were performed to evaluate if increased heart tissue concentration of fatty acids, specifically myristic, palmitic and palmitoleic acids that are believed to promote physiological heart growth, can attenuate the progression of
Autor:
Elzbieta Kompanowska-Jezierska, Alexandra Sporková, Luděk Červenka, Šárka Doleželová, Janusz Sadowski, H. Maxová, Libor Kopkan, Šárka Jíchová, Věra Čertíková Chábová, Zdeňka Vaňourková
Publikováno v:
The American journal of the medical sciences. 353(6)
Background There is vast evidence that the renin-angiotensin system is not the sole determinant of blood pressure (BP) elevation in human renovascular hypertension or the relevant experimental models. This study tested the hypothesis that kidney defi
Autor:
Šárka Jíchová, Janusz Sadowski, Zuzana Husková, Elzbieta Kompanowska-Jezierska, Libor Kopkan, John R. Falck, Herbert J. Kramer, Zdenka Vernerová, Petr Kujal, Luděk Červenka, Rami N. Reddy, Šárka Doleželová, Jan Neckář, John D. Imig
OBJECTIVE We evaluated the therapeutic effectiveness of a new, orally active epoxyeicosatrienoic acid analog (EET-A) in rats with angiotensin II (ANG II)-dependent malignant hypertension. METHODS Malignant hypertension was induced in Cyp1a1-Ren-2 tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a487f59fa61866faafe4bb44546130f
https://europepmc.org/articles/PMC5510029/
https://europepmc.org/articles/PMC5510029/
Autor:
Janusz Sadowski, Alžběta Vojtíšková, Lenka Hošková, Šárka Jíchová, Šárka Doleželová, Zuzana Husková, Josef Kautzner, Petr Kujal, Luděk Červenka, Libor Kopkan
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 38(7)
The fawn-hooded hypertensive (FHH) rat serves as a genetic model of spontaneous hypertension associated with glomerular hyperfiltration and proteinuria. However, the knowledge of the natural course of hypertension and kidney disease in FHH rats remai
Autor:
Akira Nishiyama, Zuzana Husková, Libor Kopkan, Elzbieta Kompanowska-Jezierska, Janusz Sadowski, Zdeňka Vaňourková, Šárka Doleželová, Lenka Červenková, Herbert J. Kramer, Luděk Červenka, Petra Škaroupková
Publikováno v:
Clinical and experimental pharmacologyphysiology. 43(4)
The role of the intrarenal renin-angiotensin system (RAS) in the pathophysiology of malignant hypertension is not fully understood. Accumulating evidence indicates that the recently discovered vasodilator axis of the RAS, angiotensin-converting enzym